With increasing numbers of cancer drugs being approved on shorter trials that involve fewer patients, getting accurate reports of adverse events and side effects after approval is increasingly important. Maria Delaney reports on efforts to [more]
The call for submissions for the 2016 edition of the Cancer World Journalism Award is open: outstanding pieces of journalism that contributed to reshape the way we think about cancer will be awarded a prize of [more]
Almost four in ten serious adverse drug reactions now listed in the labels of 12 targeted cancer therapies were not mentioned in the studies that led to their approval. Half the serious reactions that were [more]